On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Loretta J. Nastoupil

ResearcherPublications, citations & collaboration network

Loretta J. Nastoupil is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Loretta J. Nastoupil have?

ScholarIQindexed works

Loretta J. Nastoupil has 725 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Loretta J. Nastoupil have?

ScholarIQcitation count

Loretta J. Nastoupil has 19,664 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Loretta J. Nastoupil?

ScholarIQh-index

Loretta J. Nastoupil has an h-index of 61 in OpenAlex.

What is the i10-index of Loretta J. Nastoupil?

ScholarIQi10-index

Loretta J. Nastoupil has an i10-index of 248 in OpenAlex.

What is the ORCID of Loretta J. Nastoupil?

ScholarIQorcid

The ORCID for Loretta J. Nastoupil is on the source record.

What is the OpenAlex record for Loretta J. Nastoupil?

ScholarIQopenalex

The OpenAlex for Loretta J. Nastoupil is on the source record.

What are the most-cited papers on Loretta J. Nastoupil?

ScholarIQmost cited works
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura Porter, Igor Puzanov, Cristina Reichner, Bianca Santomasso, Carole Seigel, Alexander I. Spira, María E. Suarez‐Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson
Journal of Clinical Oncology. 20183,734 CitationsOPEN ACCESS
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla‐Osorio, Man Chun John, Paolo Strati, Beth Chasen, Enyu Dai, Minghao Dang, Neeraj Jain, Haopeng Yang, Yuanxin Wang, Shaojun Zhang, Ruiping Wang, Runzhe Chen, Jordan Showell, Sreejoyee Ghosh, Sridevi Patchva, Qi Zhang, Ryan Sun, Frederick Hagemeister, Luis Fayad, Felipe Samaniego, Hans C. Lee, Loretta J. Nastoupil, Nathan Fowler, R. Eric Davis, Jason R. Westin, Sattva S. Neelapu, Linghua Wang, Michael R. Green
Nature Medicine. 2020605 CitationsOPEN ACCESS
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
Patrizia Mondello, Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain, Haopeng Yang, Shailbala Singh, Hsia‐Yuan Ying, Chi-Shuen Chu, Man Chun John, Eneda Toska, Stefan Alig, Matthew Durant, Elisa de Stanchina, Sreejoyee Ghosh, Anja Mottok, Loretta J. Nastoupil, Sattva S. Neelapu, Oliver Weigert, Giorgio Inghirami, José Baselga, Anas Younes, Cassian Yee, Ahmet Doǧan, David A. Scheinberg, Robert G. Roeder, Ari Melnick, Michael R. Green
Cancer Discovery. 2020160 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account